Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients
References
- Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: A report from the American Heart Association. Circulation. 2023; 147(8): e93–e621. DOI: 10.1161/CIR.0000000000001137
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation. 2019; 139(25): E1082–143. DOI: 10.1161/CIR.0000000000000624
- Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010; 376(9753): 1670–1681. DOI: 10.1016/S0140-6736(10)61350-5
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140(11): e596–e646. DOI: 10.1161/CIR.0000000000000725
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020; 41(1): 111–188. DOI: 10.1093/eurheartj/ehz455
- Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022; 80(14): 1366–1418. DOI: 10.1016/j.jacc.2022.07.006
- Kulkarni KR, Garber DW, Marcovina SM, Segrest JP. Quantification of cholesterol in all lipoprotein classes by the VAP-II method. J Lipid Res. 1994; 35: 159–168. DOI: 10.1016/S0022-2275(20)40123-3
- Kulkarni KR, Garber DW, Jones MK, Segrest JP. Identification and cholesterol quantification of tow density lipoprotein subclasses in young adults by VAP-I I methodology. J Lipid Res. 1995; 36: 2291–2302. DOI: 10.1016/S0022-2275(20)39710-8
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6): 499–502. DOI: 10.1093/clinchem/18.6.499
- Martin SS, Giugliano RP, Murphy SA, et al. Comparison of low-density lipoprotein cholesterol assessment by Martin/Hopkins estimation, friedewald estimation, and preparative ultracentrifugation insights from the FOURIER trial. JAMA Cardiol. 2018; 3(8): 749–753. DOI: 10.1001/jamacardio.2018.1533
- Brownstein AJ, Martin SS. More accurate LDL-C calculation: Externally validated, guideline endorsed. Clinica Chimica Acta. 2020; 506: 149–153. DOI: 10.1016/j.cca.2020.03.030
- Nordestgaard BG, Langlois MR, Langsted A, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020; 58(4): 496–517. DOI: 10.1515/cclm-2019-1253
- Miller WG, Myers GL, Sakurabayashi I, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem. 2010; 56(6): 977–986. DOI: 10.1373/clinchem.2009.142810
- Sathiyakumar V, Park J, Golozar A, et al. Fasting versus nonfasting and low-density lipoprotein cholesterol accuracy. Circulation. 2018; 137(1): 10–19. DOI: 10.1161/CIRCULATIONAHA.117.030677
- Martin SS, Blaha MJ, Elshazly MB, et al. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol. 2013; 62(8): 732–739. DOI: 10.1016/j.jacc.2013.01.079
- Rim JH, Lee YH, Lee MH, et al. Comparison and validation of 10 equations including a novel method for estimation of LDL-cholesterol in a 168,212 Asian population. Medicine. 2016; 95(14):
e3230 . DOI: 10.1097/MD.0000000000003230 - Piani F, Cicero AFG, Ventura F, et al. Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population. Int J Cardiol. 2021; 330: 221–227. DOI: 10.1016/j.ijcard.2021.02.009
- Song Y, Lee HS, Baik SJ, et al. Comparison of the effectiveness of Martin’s equation, Friedewald’s equation, and a novel equation in low-density lipoprotein cholesterol estimation. Sci Rep. 2021; 11(1): 13545. DOI: 10.1038/s41598-021-92625-x
- Martin SS, Blaha MJ, Toth PP, et al. Very Large Database of Lipids: Rationale and design. Clin Cardiol. 2013; 36(11): 641–648. DOI: 10.1002/clc.22214
- Kulkarni KR. Cholesterol profile measurement by vertical auto profile method. Clin Lab Med. 2006; 26(4): 787–802. DOI: 10.1016/j.cll.2006.07.004
- Puavilai W, Laorugpongse D, Deerochanawong C, Muthapongthavorn Rn N, Rn S. The accuracy in using modified Friedewald equation to calculate LDL from non-fast triglyceride: A pilot study. J Med Assoc Thai. 2009; 92(2): 182–187.
- Vujovic A, Kotur-Stevuljevic J, Spasic S, et al. Evaluation of different formulas for LDL-C calculation. Lipids Health Dis. 2010; 9: 27. DOI: 10.1186/1476-511X-9-27
- Delong DM, Delong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol: The Lipid Research Clinics Prevalence Study. JAMA. 1986; 256(17): 2372–2377. DOI: 10.1001/jama.1986.03380170088024
- Ephraim RKD, Acheampong E, Swaray SM, et al. Developing a modified low-density lipoprotein (M-LDL-C) Friedewald’s equation as a substitute for direct LDL-C measure in a Ghanaian population: A comparative study. J Lipids. 2018; 2018:
7078409 . DOI: 10.1155/2018/7078409 - Ghasemi A, Asgari S, Hadaegh F, et al. New modified Friedewald formulae for estimating low-density lipoprotein cholesterol according to triglyceride levels: extraction and validation. Endocrine. 2018; 62(2): 404–411. DOI: 10.1007/s12020-018-1685-2
- Bauer F, Seibert FS, Rohn B, Babel N, Westhoff TH. Estimation of LDL cholesterol in chronic kidney disease. Eur J Prev Cardiol. 2021; 28(12): 1402–1408. DOI: 10.1093/eurjpc/zwaa003
- Hattori Y, Suzuki M, Tsushima M, et al. Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL. Atherosclerosis. 1998; 138(2): 289–299. DOI: 10.1016/S0021-9150(98)00034-3
- Anandaraja S, Narang R, Godeswar R, Laksmy R, Talwar KK. Low-density lipoprotein cholesterol estimation by a new formula in Indian population. Int J Cardiol. 2005; 102(1): 117–120. DOI: 10.1016/j.ijcard.2004.05.009
- Chen Y, Zhang X, Pan B, et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 2010; 9: 52. DOI: 10.1186/1476-511X-9-52
- Mauricio Mendes de Cordova C, Mendes de Cordova M. A new accurate, simple formula for LDL-cholesterol estimation based on directly measured blood lipids from a large cohort. Ann Clin Biochem. 2013; 50(Pt 1): 13–19. DOI: 10.1258/acb.2012.011259
- Teerakanchana T, Puavilai W, Suriyaprom K, Tungtrongchitr R. Comparative study of LDL-cholesterol levels in Thai patients by the direct method and using the Friedewald formula. Southeast Asian J Trop Med Public Health. 2007; 38(3): 519–527.
- Ahmadi SA, Boroumand MA, Gohari-Moghaddam K, Tajik P, Dibaj SM. The impact of low serum triglyceride on LDL-cholesterol estimation. Arch Iran Med. 2008; 11(3): 318–321.
- Rao A, Parker AH, El-Sheroni NA, Babelly MM. Calculation of low-density lipoprotein cholesterol with use of triglyceride/cholesterol ratios in lipoproteins compared with other calculation methods. Clin Chem. 1988; 34(12): 2532–2534. DOI: 10.1093/clinchem/34.12.2532
- Dansethakul P, Thapanathamchai L, Saichanma S, Worachartcheewan A, Pidetcha P. Determining a new formula for calculating low-density lipoprotein cholesterol: data mining approach. EXCLI J. 2015; 14: 478–483.
- Rasouli M, Mokhtari H. Calculation of LDL-cholesterol vs. direct homogenous assay. J Clin Lab Anal. 2017; 31(3):
e22057 . DOI: 10.1002/jcla.22057 - Hu CY, Lee CL, Sheu WHH, et al. A new formula for estimation of low-density lipoprotein cholesterol in an ethnic Chinese population. Clin Chem Lab Med. 2015; 53(11): 1871–1879. DOI: 10.1515/cclm-2014-1029
- Choi R, Park MJ, Oh Y, Kim SH, Lee SG, Lee EH. Validation of multiple equations for estimating low-density lipoprotein cholesterol levels in Korean adults. Lipids Health Dis. 2021; 20(1): 111. DOI: 10.1186/s12944-021-01525-6
- Saldaña Orejón IM, Benites Ricra MA, Chipana Huallpa JA. Derivación y validación de una ecuación para estimar el colesterol ligado a lipoproteínas de baja densidad en una población de Lima, Perú. Anales de la Facultad de Medicina. 2017; 78(1): 41–48. DOI: 10.15381/anales.v78i1.13020
- Molavi F, Namazi N, Asadi M, et al. Comparison common equations for LDL-C calculation with direct assay and developing a novel formula in Iranian children and adolescents: the CASPIAN V study. Lipids Health Dis. 2020; 19(1): 129. DOI: 10.1186/s12944-020-01306-7
- Martin SS, Blaha MJ, Elshazly MB, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013; 310(19): 2061–2068. DOI: 10.1001/jama.2013.280532
- Sampson M, Ling C, Sun Q, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiol. 2020; 5(5): 540–548. DOI: 10.1001/jamacardio.2020.0013
- Chowdhury N, Saiedullah M, Khan MAH, Rahman MR. Comparison of modified Friedewald’s formula with direct measurement of low-density lipoprotein cholesterol in Bangladeshi population. Bangladesh Med Res Counc Bull. 2013; 39(3): 120–123. DOI: 10.3329/bmrcb.v39i3.20312
- Sajja A, Park J, Sathiyakumar V, et al. Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels. JAMA Netw Open. 2021; 4(10):
e2128817–e2128817 . DOI: 10.1001/jamanetworkopen.2021.28817 - Giugliano RP, Keech A, Murphy SA, et al. Clinical efficacy and safety of evolocumab in high-risk patients receiving a statin: Secondary analysis of patients with low LDL cholesterol levels and in those already receiving a maximal-potency statin in a randomized clinical trial. JAMA Cardiol. 2017; 2(12): 1385–1391. DOI: 10.1001/jamacardio.2017.3944
- Kang M, Kim J, Lee SY, Kim K, Yoon J, Ki H. Martin’s equation as the most suitable method for estimation of low-density lipoprotein cholesterol levels in Korean adults. Korean J Fam Med. 2017; 38(5): 263–269. DOI: 10.4082/kjfm.2017.38.5.263
- Ferrinho C, Alves AC, Bourbon M, Duarte S. Applicability of Martin-Hopkins formula and comparison with Friedewald formula for estimated low-density lipoprotein cholesterol in e_COR study population. Revista Portuguesa de Cardiologia. 2021; 40(10): 715–724. DOI: 10.1016/j.repc.2020.11.011
- Martin SS, Ditmarsch M, Simmons M, et al. Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition. Eur Heart J Cardiovasc Pharmacother. 2022;
pvac056 . DOI: 10.1093/eurheartj/ehac544.2359 - Meeusen JW, Lueke AJ, Jaffe AS, Saenger AK. Validation of a proposed novel equation for estimating LDL cholesterol. Clin Chem. 2014; 60(12): 1519–1523. DOI: 10.1373/clinchem.2014.227710
- Pallazola VA, Sathiyakumar V, Ogunmoroti O, et al. Impact of improved low-density lipoprotein cholesterol assessment on guideline classification in the modern treatment era-Results from a racially diverse Brazilian cross-sectional study. J Clin Lipidol. 2019; 13(5): 804–811.e2. DOI: 10.1016/j.jacl.2019.07.002
- Chaen H, Kinchiku S, Miyata M, et al. Validity of a novel method for estimation of low-density lipoprotein cholesterol levels in diabetic patients. J Atheroscler Thromb. 2016; 23(12): 1355–1364. DOI: 10.5551/jat.35972
- Mehta R, Reyes-Rodríguez E, Yaxmehen Bello-Chavolla O, et al. Performance of LDL-C calculated with Martin’s formula compared to the Friedewald equation in familial combined hyperlipidemia. Atherosclerosis. 2018; 277: 204–210. DOI: 10.1016/j.atherosclerosis.2018.06.868
- Wilson PW, Jacobson TA, Martin SS, et al. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group. J Clin Lipidol. 2021; 15(5): 629–648. DOI: 10.1016/j.jacl.2021.09.046
- Scartezini M, Ferreira CE dos S, Izar MCO, et al. Positioning about the flexibility of fasting for lipid profiling. Arq Bras Cardiol. 2017; 108(3): 195–197. DOI: 10.5935/abc.20170039
- Langlois MR, Nordestgaard BG, Langsted A, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020; 58(4): 496–517. DOI: 10.1515/cclm-2019-1253
- Ray KK, Ference BA, Séverin T, et al. World Heart Federation cholesterol roadmap 2022. Glob Heart. 2022; 17(1): 75. DOI: 10.5334/gh.1154
- Whelton SP, Meeusen JW, Donato LJ, et al. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method. J Clin Lipidol. 2017; 11(4): 1065–1072. DOI: 10.1016/j.jacl.2017.05.005
- Al Rifai M, Martin SS, McEvoy JW, et al. The prevalence and correlates of subclinical atherosclerosis among adults with low-density lipoprotein cholesterol. Atherosclerosis. 2018; 274: 61–66. DOI: 10.1016/j.atherosclerosis.2018.04.021
- Bauer F, Seibert FS, Rohn B, Babel N, Westhoff TH. Estimation of LDL cholesterol in chronic kidney disease. Eur J Prev Cardiol. 2021; 28(12): 1402–1408. DOI: 10.1093/eurjpc/zwaa003
- Choi SY, Park HE, Kim MK, et al. Difference between calculated and direct-measured low-density lipoprotein cholesterol in subjects with diabetes mellitus or taking lipid-lowering medications. J Clin Lipidol. 2012; 6(2): 114–120. DOI: 10.1016/j.jacl.2011.12.007
- Fawwad A, Sabir R, Riaz M, Moin H. Measured versus calculated LDL-cholesterol in subjects with type 2 diabetes. Pak J Med Sci. 2016; 32(4): 955. DOI: 10.12669/pjms.324.9896
- Hopkins PN, Brinton EA, Nanjee MN. Hyperlipoproteinemia type 3: The forgotten phenotype. Curr Atheroscler Rep. 2014; 16(9). DOI: 10.1007/s11883-014-0440-2
- Chung BH, Wilkinson T, Geer JC, Segrest JP. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res. 1980; 21(3): 284–291. DOI: 10.1016/S0022-2275(20)39807-2
DOI: https://doi.org/10.5334/gh.1214 | Journal eISSN: 2211-8179
Language: English
Submitted on: Dec 15, 2022
Accepted on: May 26, 2023
Published on: Jun 19, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Christeen Samuel, Jihwan Park, Aparna Sajja, Erin D. Michos, Roger S. Blumenthal, Steven R. Jones, Seth S. Martin, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.